Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,168
datasets available to search
ShareScore release 0.9.0
Dataset results
3,168 results for “Subjective Evaluation”
A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE
ClinicalTrials.gov study NCT03312907. IPD Sharing: YES. Countries: 11. Publications: 5.
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
ClinicalTrials.gov study NCT00880399. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)
ClinicalTrials.gov study NCT00926185. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Multiple-Dose Research Study on Safety Evaluation of the GD Antrodia Camphorata in 30 Healthy Adult Subjects
ClinicalTrials.gov study NCT01007656. IPD Sharing: YES. Countries: 1. Publications: 1.
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
ClinicalTrials.gov study NCT01486264. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation
ClinicalTrials.gov study NCT02564354. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome
ClinicalTrials.gov study NCT01743001. IPD Sharing: Not stated. Countries: 21. Publications: 1.
Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™
ClinicalTrials.gov study NCT00875485. IPD Sharing: YES. Countries: 2. Publications: 2.
A Study Evaluating the Efficacy and Safety of VX-445/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects, Homozygous for F508del
ClinicalTrials.gov study NCT04105972. IPD Sharing: NO. Countries: 4. Publications: 3.
A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures
ClinicalTrials.gov study NCT01618695. IPD Sharing: Not stated. Countries: 7. Publications: 2.
A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation
ClinicalTrials.gov study NCT02516410. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma
ClinicalTrials.gov study NCT00679263. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03410992. IPD Sharing: NO. Countries: 9. Publications: 7.
BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects
ClinicalTrials.gov study NCT00856843. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
ClinicalTrials.gov study NCT03461146. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso
ClinicalTrials.gov study NCT03950739. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03370133. IPD Sharing: NO. Countries: 11. Publications: 10.
A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
ClinicalTrials.gov study NCT01597492. IPD Sharing: YES. Countries: 1. Publications: 1.
Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL
ClinicalTrials.gov study NCT02910063. IPD Sharing: YES. Countries: 8. Publications: 1.
A Study to Evaluate Efficacy and Safety of TEZ/IVA in Subjects Aged 6 Through 11 Years With Cystic Fibrosis
ClinicalTrials.gov study NCT03559062. IPD Sharing: Not stated. Countries: 9. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.